Nuclear Power in Taiwan : Capacity, Generation, Investment Trends, Regulations and Company Profiles



Wise.Guy.

Nuclear Power in Taiwan, Market Outlook to 2030 Capacity, Generation, Investment Trends, Regulations and Company Profiles

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides in depth analysis on global nuclear power market with forecasts up to 2030. The report analyzes the power market scenario in Taiwan (includes thermal conventional, nuclear, large hydro, pumped storage and renewables) and provides future outlook with forecasts up to 2030. The research details nuclear power market outlook in the country and provides forecasts up to 2030. The report highlights installed capacity and power generation trends from 2006 to 2030 in Taiwan nuclear power market. A detailed coverage of nuclear energy policy framework governing the market with specific policies pertaining to nuclear is provided in the report. The research also provides details of active nuclear reactors in the country, market size of major equipment and company snapshot of some of the major market participants.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729539-nuclear-power-in-taiwan-and-company-profiles

Scope
– A brief introduction on global carbon emissions and global primary energy consumption.
– Historical period is during 2006-2015 (unless specified) and forecast period is for 2015-2030.
– Overview on the global nuclear power market with installed capacity and generation trends, installed capacity split by region in 2015, installed capacity split by major nuclear power countries in 2015 and investment trends.
– Power market scenario in Taiwan provides detailed market overview, installed capacity and power generation trends by various fuel types (includes thermal conventional, nuclear, large hydro and renewables) with forecasts up to 2030.
– Details of Taiwan nuclear power market with installed capacity and generation trends, installed capacity by reactor type, installed capacity share by contractor/owner and information on major active and upcoming projects.
– Key policies and regulatory framework supporting nuclear power development.
– Company snapshots of some of the major market participants in the country.

Reasons to buy
– The report will enhance your decision making capability in a more rapid and time sensitive manner.
– Identify key growth and investment opportunities in Taiwan nuclear power market.
– Facilitate decision-making based on strong historic and forecast data for nuclear power market.
– Position yourself to gain the maximum advantage of the industry’s growth potential.
– Identify key partners and business development avenues.
– Understand and respond to your competitors’ business structure, strategy and prospects.

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Executive Summary 7
2.1 Nuclear Power to Grow at a Slower Pace than Other Power Generating Sources 7
2.2 Thermal Power Accounts for Three-Fourth of the Power Capacity in Taiwan 7
2.3 Taiwan Plans to Decommission Nuclear Power Capacity by 2025 9
3 Introduction 10
3.1 Carbon Emissions, Global, 2001-2015 10
3.2 Primary Energy Consumption, Global, 2001-2025 12
3.3 Report Guidance 15
4 Nuclear Power Market, Global, 2006-2030 16
4.1 Nuclear Power Market, Global, Overview 16
4.2 Nuclear Power Market, Global, Installed Capacity, 2006-2030 17
4.2.1 Nuclear Power Market, Global, Installed Capacity Share by Region, 2015 and 2030 19
4.2.2 Nuclear Power Market, Global, Installed Capacity Share by Country, 2015 and 2030 21
4.3 Nuclear Power Market, Global, Power Generation, 2006-2030 23
4.3.1 Nuclear Power Market, Global, Generation Share by Region, 2015 and 2030 25
4.3.2 Nuclear Power Market, Global, Generation Share by Country, 2015 and 2030 27
5 Power Market, Taiwan, 2006-2030 29
5.1 Power Market, Taiwan, Overview 29
5.2 Power Market, Taiwan, Installed Capacity, 2006-2030 30
5.2.1 Power Market, Taiwan, Cumulative Installed Capacity by Fuel Type, 2006-2030 30
5.2.2 Power Market, Taiwan, Share in Cumulative Installed Capacity Split by Source Type, 2015 and 2030 32
5.3 Power Market, Taiwan, Power Generation, 2006-2030 34
6 Nuclear Power Market, Taiwan, 2006-2030 36
6.1 Nuclear Power Market, Taiwan, Overview 36
6.2 Nuclear Power Market, Taiwan, Installed Capacity, 2006-2030 37
6.3 Nuclear Power Market, Taiwan, Power Generation, 2006-2030 39
6.4 Nuclear Power Market, Taiwan, Project Based Analysis, 2015 41
6.4.1 Nuclear Power Market, Taiwan, Top Operational Nuclear Reactor, 2015 41
6.4.2 Nuclear Power Market, Taiwan, Top Active Nuclear Reactor Sites, 2015 42
6.5 Nuclear Power Market, Taiwan, Investment Analysis, 2015 43
6.5.1 Nuclear Power Market, Taiwan, Deal Volume vs. Deal Value, 2006-2015 43
7 Power Market, Taiwan, Regulatory Scenario 45
7.1 Overview 45
7.2 Power Sector Policies 46
7.2.1 The Electricity Act 46
7.2.2 The Petroleum Administration Act 46
7.3 Renewable Energy Development Act 46
7.4 Renewable Energy Targets 47
7.5 Renewable Energy Incentives 47
7.6 New Offshore Wind Power Development Incentive Program 48
7.7 Taiwan Smart Grid Deployment Project 49
7.8 Greenhouse Gas Management and Reduction Act 49
8 Nuclear Power Market, Taiwan, Company Profiles 50
8.1 Company Snapshot: Westinghouse Electric Company, LLC 50
8.1.1 Westinghouse Electric Company, LLC – Company Overview 50
8.1.2 Westinghouse Electric Company, LLC – Business Description 50
8.1.3 Westinghouse Electric Company, LLC – SWOT Analysis 51
8.1.4 Westinghouse Electric Company, LLC – Major Products and Services 56
8.1.5 Westinghouse Electric Company, LLC – Head Office 58
8.2 Company Snapshot: Taiwan Power Company, Ltd. 59
8.2.1 Taiwan Power Company, Ltd. – Company Overview 59
8.2.2 Taiwan Power Company, Ltd. – Business Description 59
8.2.3 Taiwan Power Company, Ltd. – SWOT Analysis 60
8.2.4 Taiwan Power Company, Ltd. – Major Products and Services 64
8.2.5 Taiwan Power Company, Ltd. – Head Office 64
8.3 Company Snapshot: GE-Hitachi Nuclear Energy, Inc. 65
8.3.1 GE-Hitachi Nuclear Energy, Inc. – Company Overview 65
8.3.2 GE-Hitachi Nuclear Energy, Inc. – Major Products and Services 65
8.3.3 GE-Hitachi Nuclear Energy, Inc. – Head Office 66
8.4 Company Snapshot: Bechtel Corporation 67
8.4.1 Bechtel Corporation – Company Overview 67
8.4.2 Bechtel Corporation – Business Description 67
8.4.3 Bechtel Corporation – SWOT Analysis 69
8.4.4 Bechtel Corporation – Major Products and Services 73
8.4.5 Bechtel Corporation – Head Office 74

Access Report @ https://www.wiseguyreports.com/reports/729539-nuclear-power-in-taiwan-and-company-profiles

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Indian Mayonnaise & Salad Dressing Market to Grow at a 24.72% CAGR Forecast to 2021

Mayonnaise & Salad Dressing India Market Segmentation and Major Players Analysis and Forecast to 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The mayonnaise and salad dressing market is emerging as one of the rapidly growing dynamic markets in food services sector in India. Due to increasing standard of living and changing lifestyle, the demand for sophisticated taste in meal is becoming a growing trend in the food industry that is making a positive impact on mayonnaise and salad dressing markets. The various mayonnaise and salad dressing products like mustard sauce, caeser salad dressing, creamy cheese salad dressings, liquid salad dressing sauces, Italian & Russian salad dressing, thousand island salad dressing, eggless and garlic mayonnaise are greater than ever, thereby providing high impetus to the Indian mayonnaise and salad dressing market. The elite class demands quality, tasty and ready to eat meal turning out to be the greatest driver to the use of salad dressings and mayonnaise in recipes.
Request a sample report @ https://www.wiseguyreports.com/sample-request/744781-india-mayonnaise-salad-dressing-market-outlook-2021
Mayonnaise is an integral ingredient which is used by branded food chains like Macdonald, Subway, KFC, Dominos, Pizza Hut, etc and these are the leading end users for the mayonnaise market. The mayonnaise and salad dressing market is legroom for new product developments and producers are trying to convince consumers through aggressive campaign and advertising that they should adopt such products to experiment new dishes at home by using mayonnaise and salad dressing sauces in the recipes. However, the penetration of mayonnaise and salad dressing market is extremely low, but this opens the door for new and enormous opportunities in Indian mayonnaise and salad dressing industry.

India Mayonnaise & Salad Dressing Market is growing with a CAGR of 21.54% from last five years and is projected to get more than thrice t by the 2021 due to growing trend of international food, brand awareness, increasing disposable income, growing demand in middle class people and increasing international food chains. The unorganized market in this industry is lagging compared to organized industry; as institutional food players focus on quality mayonnaise and salad dressings rather than prices so that they only consume the branded mayonnaise and salad dressing variants.

According to “India Mayonnaise & Salad Dressing Market Outlook 2021”, India’s mayonnaise and salad dressing market is predicted to increase at a CAGR of 24.72% over six years. Fun Foods, Cremica, Del Monte, Sil, Kraft and American Garden are operating market in the organized mayonnaise and salad dressing market. Eggless mayonnaise dominates the mayonnaise market along with its various variants. Fun Foods is leading in mayonnaise category from many decades. Metro cities of India account for a considerable market share in the sales of mayonnaise an salad dressing products, with various variants are growing rapidly among upper middle class consumers.
Complete report details @ https://www.wiseguyreports.com/reports/744781-india-mayonnaise-salad-dressing-market-outlook-2021
Key points in table of content
1. Executive Summary
2. India Mayonnaise & Salad Dressing Market Outlook
2.1. Market Size
2.1.1. By Value
2.1.2. By Volume
2.2. Market Share By Segment
3. Mayonnaise Market Outlook
3.1. Market Size
3.1.1. By Value
3.1.2. By Volume
3.2. Market Share
3.2.1. By Brand
3.2.2. By Types
3.2.3. By Organized & Unorganized
3.2.4. By End user (institutional, retail)
3.3. Pricing Analysis
3.4. Raw Material
3.5. Unorganized market Outlook
4. Salad Dressing market Outlook
4.1. Market Size
4.1.1. By Value
4.1.2. By Volume
4.2. Market Share
4.2.1. By Brand
4.2.2. By Types
4.2.3. By Organized & Unorganized
4.2.4. By End User
4.3. Pricing Analysis
4.4. Raw Materials
4.5. Unorganized market Outlook
5. India Economic Snapshot
6. Policy & Regulatory Landscape
7. Mayonnaise & Salad Dressing Market Trade Dynamics
7.1. Imports
7.2. Export
8. Channel Partner Analysis
9. Mayonnaise & Salad Dressing Market Dynamics
9.1. Key Drivers
9.2. Key Challenges
10. Market Trends & Developments
10.1. The Traditional Pairs
10.2. Diversifying uses of dressing
10.3. Diversity in Flavors and Brands
10.4. Populations Influence Market
11. Competitive Landscape
11.1. Porters Five Forces
11.2. Company Profile
11.2.1. Fun Foods
11.2.2. Cremica
11.2.3. Del Monte
11.2.4. Remia
11.2.5. American Garden
11.2.6. Scandic Food (SIL)
11.2.7. Kraft
12. Strategic Recommendations
Disclaimer
Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=744781
Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Facial Fat Transfer Market is Expected to Reach US ~$4.20 Billion by 2022

Facial fat transfer Market Information, by Types (Autologous Fat Transfer) by treatment types (fat injections) – Forecast to 2022

Key Players: Galderma S.A., ALLERGAN, Merz Pharma, Valeant, Integra LifeSciences Corporation.

— Market Research Future

PUNE, MAHARASHTRA, INDIA, November 16, 2016 /EINPresswire.com/ — Market Research Future has a half cooked research report on global facial fat transfer market. The global facial fat transfer market is expected to reach US ~4.20 billion during the period 2016 to 2022 from USD 1.50 billion in 2015.

Market Highlights:
The global facial fat transfer market has been examined as a progressing market and expected to grow at a tremendous rate. There is huge demand for facial fat transfer in North America and Europe where as region like Asia Pacific is expected to be a growing market. As there is increasing acceptance of soft tissue fillers and increasing success rate of these procedures are some of the factors driving the growth of the market. Further factors such as the complications and risks involved in the surgery are hindering the growth of the Market

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “The Global Facial Fat transfer Market Research Report -Forecast to 2022”.

Market Research Analysis:
Facial fat transfer types and the treatment for the same are expected to evolve massively in the near future. Growing technology in the healthcare industry plays a major role in the growth of this market as new techniques have been evolved since the establishment of these treatments which are more effective and efficient, which makes these treatments more popular and the demand for these tests will grow eventually.

Key Players of Facial Fat Transfer Market:
• Galderma S.A.
• Allergan
• Merz Pharma
• Valeant
• Integra Lifesciences Corporation
• Sanofi
• Sinclair Pharma
• SciVision Biotech Inc.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample-request/facial-fat-transfer-market-research-report-global-forecast-to-2022

Brief TOC for Facial Fat Transfer:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Facial Fat Transfer Market, By Type
5.1 Microlipoinjection
5.2 Autologous Fat Transfer

Continue…

Intended Audience:
• Facial fat transfer treatment equipment manufacturers & suppliers
• Facial fat transfer drug manufacturers & suppliers
• Pharmaceutical and biotechnology companies
• Hospitals and diagnostic centers
• Academic research institutes

Related Report:
Global Astigmatism Market Information, by type (Myopic Astigmatism, Hyperopic Astigmatism and others), by treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries and others), by end user (Hospital, Clinics and others) – Forecast to 2022.
Know more about this report @ https://www.marketresearchfuture.com/reports/astigmatism-market-research-report-global-forecast-to-2022

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here

Source: EINPresswire.com

Indian LED Lighting Market to Grow at a 32.15% CAGR Forecast to 2021

LED Lighting India Market Segmentation and Major Players Analysis and Forecast to 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Light Emitting Diodes (LEDs) have entered the lighting market, not even a decade before, as an energy efficient alternative to traditional light sources such as incandescent and fluorescent bulbs. These lights still have an enormous amount of room for technological growth and offer various advantages over all other forms of lighting. Having just recently entered the lighting market, LEDs have faced many barriers to entry and are struggling to obtain a market share over the traditional forms of lights. Compact fluorescent lamps (CFL) also used to be a disruptive technology, but it took over 20 years to achieve significant market share.
Request a sample report @ https://www.wiseguyreports.com/sample-request/744778-india-led-lighting-market-outlook-2021

India Lighting market is growing with a CAGR of 16.83% from last five years and is projected to grow even in future due to excellent growth in the LED Lighting industry. LED Lighting market is growing with a whopping CAGR of 57.31% over last five years. Government initiatives to replace incandescent bulbs with LED bulbs under various schemes, increasing energy demand in the country and declining prices of LED lights are the factors driving the growth of LED lighting in India.

According to “India LED Lighting Market Outlook 2021”, India’s LED Lighting market is forecast to grow at a CAGR of 32.15% over six years. LED Lighting, which accounts for 19% share in the current overall Lighting market, is anticipated to reach 62% by the year 2021. The report reveals that Philips, Surya Roshni, Osram, Bajaj, Havells, etc. are the leading players in India Lighting market and are expected to dominate the market in the forecast period also. The growing awareness about LED lighting in the Southern India has proved to be the important market for LED lighting companies. Street lighting application accounts for majority of the market revenues in India LED lighting market. Outdoor LED lighting segment is growing robustly on account of growing demand for LED installations in parks, streets, railways, metro stations, parking lots and other public places. “India LED Lighting Market Outlook 2021” discusses the following aspects of LED Lighting in India
Complete report details @ https://www.wiseguyreports.com/reports/744778-india-led-lighting-market-outlook-2021
Key points in table of content
1. Executive Summary
2. Global LED Lighting Market Outlook
2.1. Market Size – By Value
2.1.1. Lighting Market
2.1.2. LED Lighting Market
2.2. Market Share
2.2.1. By Region
2.2.2. By Application
2.2.3. By LED Technology
2.3. Pricing Analysis
3. India LED Lighting Market Outlook
3.1. Market Size – By Value
3.1.1. Lighting Market
3.1.2. LED lighting Market
3.2. Market Share
3.2.1. By Company
3.2.2. By Region
3.2.3. By Types
3.2.4. By Application
3.3. Pricing Analysis
4. Production Procedure
5. India Economic Profile 2014
6. Raw Material
7. Policy & Regulatory Landscape
8. Organized Vs Unorganized Market
9. PEST Analysis
10. India LED Lighting Market Trade Dynamics
10.1. Import
10.2. Export
11. Channel Partner Analysis
12. Market Dynamics
12.1. Key Drivers
12.2. Key Challenges
13. Market Trends & Developments
13.1. Outdoor Applications
13.2. Buying Trend in Metropolitan Cities
13.3. Indian Products Vs Imported Products
13.4. Thinner Smartphone Backlight LEDs
14. Competitive Landscape
14.1. Porter’s Five Forces
14.2. Company Profiles
14.2.1. Philips India Ltd.
14.2.2. Bajaj Electricals Ltd.
14.2.3. General Electric Company
14.2.4. Havells India Ltd.
14.2.5. Osram India Pvt. Ltd.
14.2.6. Syska Led Lights Pvt. Ltd.
14.2.7. Reiz India
14.2.8. Eveready Industries India Ltd.
14.2.9. Moser Baer India Ltd.
14.2.10. Crompton Greaves
15. Strategic Recommendations
16. Disclaimer
Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=744778
Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Surgical Mesh : Medical Devices Pipeline Assessment, 2016



Wise.Guy.

Surgical Mesh Medical Devices Pipeline Assessment 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Mesh pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729488-surgical-mesh-medical-devices-pipeline-assessment-2016

Scope
– Extensive coverage of the Surgical Mesh under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Surgical Mesh and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Surgical Mesh under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Surgical Mesh Overview 8
3 Products under Development 9
3.1 Surgical Mesh – Pipeline Products by Stage of Development 9
3.2 Surgical Mesh – Pipeline Products by Territory 10
3.3 Surgical Mesh – Pipeline Products by Regulatory Path 11
3.4 Surgical Mesh – Pipeline Products by Estimated Approval Date 12
3.5 Surgical Mesh – Ongoing Clinical Trials 13
4 Surgical Mesh – Pipeline Products under Development by Companies 14
4.1 Surgical Mesh Companies – Pipeline Products by Stage of Development 14
4.2 Surgical Mesh – Pipeline Products by Stage of Development 16
5 Surgical Mesh Companies and Product Overview 18
5.1 Acera Surgical, Inc. Company Overview 18
5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Admedus Ltd Company Overview 19
5.2.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Anika Therapeutics, Inc. Company Overview 21
5.3.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Boston Scientific Corporation Company Overview 23
5.4.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 DSM Biomedical B.V. Company Overview 25
5.5.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Ethicon Inc Company Overview 29
5.6.1 Ethicon Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Fibralign Corporation Company Overview 31
5.7.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Harbor MedTech, Inc. Company Overview 35
5.8.1 Harbor MedTech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 John Hopkins University Company Overview 38
5.9.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 38
5.10 Medisse BV Company Overview 39
5.10.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 39
5.11 Medlinx Acacia Pte Ltd Company Overview 41
5.11.1 Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Medtronic plc Company Overview 42
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 MiMedx Group, Inc Company Overview 44
5.13.1 MiMedx Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 PolyNovo Biomaterials Pty Ltd Company Overview 46
5.14.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Proxy Biomedical Limited Company Overview 47
5.15.1 Proxy Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 Retectix, LLC Company Overview 48
5.16.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Revivicor, Inc. Company Overview 49
5.17.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Samyang Biopharmaceuticals Corporation Company Overview 50
5.18.1 Samyang Biopharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Soft Tissue Regeneration, Inc. Company Overview 51
5.19.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Teleflex Incorporated Company Overview 52
5.20.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Tepha, Inc. Company Overview 54
5.21.1 Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.22 The Electrospinning Company Ltd Company Overview 55
5.22.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.23 University of Maryland, Baltimore Company Overview 56
5.23.1 University of Maryland, Baltimore Pipeline Products & Ongoing Clinical Trials Overview 56
5.24 University of South Florida Company Overview 57
5.24.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 57
6 Surgical Mesh- Recent Developments 58
6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 58
6.2 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 59
6.3 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 60
6.4 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 61

Access Report @ https://www.wiseguyreports.com/reports/729488-surgical-mesh-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Internet of Things (IoT) in Transportation Market to Grow at a 17%CAGR Forecast to 2020

Global Internet of Things (IoT) in Transportation Market 2016 Share, Trend, Segmentation and Forecast to 2020

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Description

The report ‘Global Internet of Things (IoT) in Transportation Market by Technology (Navigation System, Telematics, Infotainment, ADAS, Semiconductor, Sensors) – Outlook 2020” provides an in-depth analysis of incorporation of IoT in transportation segment which is expected to grow at a CAGR of 17% in the forecasted period 2016-20. The report is segmented on the basis of major technologies used to enable this with detailed current and forecasted market outlook.

Request a sample report @ https://www.wiseguyreports.com/sample-request/721398-global-internet-of-things-sensors-outlook-2020

Growth of the industry is fuelled by emergence of driverless cars, enhanced safety feature with use of ADAS, Government support and higher efficiency in transportation and logistics with connectivity. However, rise of cyber threat with IoT in transportation, integration complexities of disparate systems and security and privacy risks associated with connectivity solutions are the major factors restraining the growth and adoption of IoT solutions in transportation segment. Global IoT Transportation market is dominated by few major companies, of which Alcatel Lucent, AT&T and Cisco Systems Inc have been profiled in the report.

Technological Coverage

• Navigation Systems
• Navigation Systems
• Automotive Semiconductor
• Telematics
• Infotainment
• ADAS
• Sensors

Key Vendors

• Alcatel-Lucent
• AT&T
• Cisco Systems

Complete report details @ https://www.wiseguyreports.com/reports/721398-global-internet-of-things-sensors-outlook-2020

Table Of Contents

Executive Summary

2. Research Methodology

3. Internet of Things

3.1 Overview
3.2 Market Size
3.3 Applications

4. IoT in Transportation Industry

4.1 Overview
4.1.1 Benefits of IoT in Transportation
4.2 Intelligent Transportation Systems (ITS)
4.2.1 ITS – Brief History
4.3 Market Size (Actual & Foreacsted)

5. IoT in Transportation by Technology

5.1 Navigation Systems

5.1.1 Overview
5.1.2 Market Size in Road Transport (Actual & Forecasted)
5.1.3 Market Size in Air Transport (Actual & Forecasted)
5.1.4 Market Size in Rail Transport (Actual & Forecasted)
5.1.5 Market Size in Maritime (Actual & Forecasted)

5.2 Automotive Semiconductor

5.2.1 Overview
5.2.2 Market Size (Actual & Forecasted)
5.2.3 Market Share by Category
5.2.4 Market Share by Competitors

5.3 Automotive Telematics

5.3.1 Overview
5.3.2 Market Size (Actual & Forecasted)
5.3.3 Market Share by Category

5.4 Automotive Infotainment

5.4.1 Overview
5.4.2 Market Size (Actual & Forecasted)
5.4.3 Market Share by Operating System
5.4.4 Market Share by Competitors

5.5 ADAS

5.5.1 Overview
5.5.2 Market Sizing (Actual & Forecasted)

5.6 Sensors

5.6.1 Overview
5.6.2 Market Size (Acutal & Forecasted)

5.7 RFID

5.8 NFC Technology

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Emergence of Driverless Cars
6.1.2 Enhanced Safety Feature with ADAS
6.1.3 Government Support
6.1.4 Higher efficiency in Transportation & Logistics

6.2 Challenges

6.2.1 Rise of Cyber threat
6.2.2 Integration complexities
6.2.3 Security & Privacy Risk

7. Market Trends

7.1 Advent of Connected Cars
7.2 Intelligent Mobility
7.3 ‘Onboard Diagnostics’ in Logistics
7.4 High Positional accuracy for Automoblies using UDR

8. Competitive Landscape

10. Company Profiles

10.1 Alcatel Lucent

10.1.1 Business Overview
10.1.2 Financial Overview
10.1.3 Business Strategies

10.2 AT&T

10.2.1 Business Overview
10.2.2 Financial Overview
10.2.3 Business Strategies

10.3 Cisco Systems Inc

10.3.1 Business Overview
10.3.2 Financial Overview
10.3.3 Business Strategies

Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=721398

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Minimally Invasive Surgical (MIS) Devices:Medical Devices Pipeline Assessment 2016



Wise.Guy.

Minimally Invasive Surgical (MIS) Devices Medical Devices Pipeline Assessment, 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Scope
– Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Minimally Invasive Surgical (MIS) Devices Overview 9
3 Products under Development 10
3.1 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Stage of Development 10
3.2 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Territory 11
3.3 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Regulatory Path 12
3.4 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Estimated Approval Date 13
3.5 Minimally Invasive Surgical (MIS) Devices – Ongoing Clinical Trials 14
4 Minimally Invasive Surgical (MIS) Devices – Pipeline Products under Development by Companies 15
4.1 Minimally Invasive Surgical (MIS) Devices Companies – Pipeline Products by Stage of Development 15
4.2 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Stage of Development 17
5 Minimally Invasive Surgical (MIS) Devices Companies and Product Overview 18
5.1 Actuated Medical, Inc. Company Overview 18
5.1.1 Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 BriteSeed Company Overview 20
5.2.1 BriteSeed Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Delft University of Technology Company Overview 21
5.3.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 DistalMotion Company Overview 24
5.4.1 DistalMotion Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 ES Vascular Ltd. Company Overview 26
5.5.1 ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Ethicon Endo-Surgery, Inc. Company Overview 27
5.6.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Eximis Company Overview 28
5.7.1 Eximis Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 FlexDex Company Overview 29
5.8.1 FlexDex Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Fortimedix B.V. Company Overview 31
5.9.1 Fortimedix B.V. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Hadassah Medical Center Company Overview 32
5.10.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Human Extensions LTD Company Overview 33
5.11.1 Human Extensions LTD Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Imperial College London Company Overview 34
5.12.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 John Hopkins University Company Overview 35
5.13.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Osaka University Company Overview 36
5.14.1 Osaka University Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Rambam Health Care Campus Company Overview 37
5.15.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 Signum Surgical Ltd Company Overview 38
5.16.1 Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 Technische Universiteit Eindhoven Company Overview 39
5.17.1 Technische Universiteit Eindhoven Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 UltraSurge Technologies Ltd. Company Overview 40
5.18.1 UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 University of California, San Francisco Company Overview 41
5.19.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 University of Wisconsin Madison Company Overview 45
5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Varada Innovations Inc. Company Overview 47
5.21.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 VenX Medical LLC Company Overview 48
5.22.1 VenX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 XACT Robotics Ltd. Company Overview 51
5.23.1 XACT Robotics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
6 Minimally Invasive Surgical (MIS) Devices- Recent Developments 52
6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52
6.2 Oct 26, 2016: Life Spine Achieves 32% Sales Growth and Announces Industry’s Largest Post-Packing Capabilities for Lateral Fusion 52
6.3 Oct 18, 2016: Intuitive Surgical Announces Third Quarter Earnings 53
6.4 Oct 17, 2016: Fortimedix Surgical Announces the U.S. Launch of symphonX Surgical Platform, the World’s Lowest Profile Single-Port Surgery Solution, During American College of Surgeons Clinical Congress 2016 54
6.5 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 54

Access Report @ https://www.wiseguyreports.com/reports/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Pharma Parallel Trade: Beyond Brexit and EU Falsified Medicine Directive

Parallel Trade 2017

SMi Group (2016.11.16 London) Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.

The best Parallel Trade conference of the last 5 years!

— Past Attendee of Parallel Trade 2016

LONDON, LONDON, UNITED KINGDOM, November 16, 2016 /EINPresswire.com/ — With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? SMi’s Parallel Trade conference will be returning to London next February 6th-7th, for its 11th year, to discuss short term and long term concerns of pharma manufacturers, regulators and parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges.

Parallel Trade 2017 official website is www.parallel-trade.com/EIN

Dr Rick Greville, Director Wales and Director Distribution & Supply for The Association of the British Pharmaceutical Industry will be speaking on “The European Commission's Falsified Medicines Directive – recent updates”. Dr. Gr0eville will discuss what progress has been made since February 2016 and what the market participants need to know about "product information templates", and much more.

Other key topics to be discussed during the 2-day conference are: What will Brexit mean for parallel trade to and from the UK? Parallel Trade 101 – Which factors determine the flow of pharmaceutical products in Europe? Beyond pharmaceutical products – parallel imports of medical devices. The Patient’s perspective.

The event programme also features three panel debates on: Shortages; Challenges and opportunities for parallel traders; Technology & new trends; and two exclusive post conference workshops on “Understanding IP and competition law issues in parallel trade” (Hosted by Kathy Osgerby, Associate and Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP) and “Parallel Trade – Management Strategies” (Hosted by Janice Haigh, Practice Leader, Market Access, Quintiles).

For further information please refer to www.parallel-trade.com/EIN

Expert Speakers Line up for 2017 includes: The Association of the British Pharmaceutical Industry (Dr Rick Greville, Director Distribution & Supply), Shire International GmbH (Eric Noehrenberg, Director, Regional Market Access Lead, Latin America), Delfarma (Tomasz Dzitko, President), European Association for Euro-Pharmaceutical Companies (Heinz Kobelt, Director European Affairs), ISPOR (Vladimir Zah, Health Economics Consultant), Abacus Medicine (Flemming Wagner, CEO), IMS Health (Alexey Savin, Principal Russia and CIS), Arnold & Porter (UK) LLP (Kathy Osgerby, Associate, and Karoline Zwierzynska, Associate), Europe Economics (Dermot Glynn, Senior Advisor), European Alliance for Access to Save Medicines (Mike Isles, Executive Director), Research Health (Dr Andrew Stainthorpe, Director Market Access and Managed Entry) and many more.

The complete 2-day event programme is available for complimentary download at www.parallel-trade.com/EIN
Latest confirmed attendees include senior representatives from Astellas Pharma, AstraZeneca, Teva UK, Vifor Pharma, Janssen Pharmaceutica NV, Napp Laboratories, Kantar Health, Ferring Pharmaceuticals, LEO Pharma, AstraZeneca Czech Republic, Swedish Orphan Biovitrum AB, Amgen, Novartis Pharmaceuticals, Novartis Turkey, LEO Pharma, Johnson & Johnson, Novo Nordisk Pharma, Daiichi Sankyo Europe GmbH, Sunovion Pharmaceuticals Europe Ltd and many more.
Feedback from past attendees of SMi Group’s Parallel Trade: “Interesting conference, generating a good debate from all sides”, “Great conference! Audience very enthusiastic and actively participating in discussions”, “Very good discussing about pricing issues and competition”, “Overall, a very positive experience!”, “The best Parallel Trade conference of the last 5 years!”.

11th annual Parallel Trade
6-7 February 2017, Holiday Inn Kensington Forum, London, UK
www.parallel-trade.com/EIN
Sponsorship, Exhibition contact: Alia Malick, +44 (0) 207 827 6168, amalick@smi-online.co.uk
Delegates/Group contact: Fateja Begum, +44 (0) 207 827 6184, fbegum@smi-online.co.uk
Media Contact: jrotar@smi-online.co.uk
______________________________end of press-release______________________
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Julia Rotar
SMi Group
2078276088
email us here

Source: EINPresswire.com

Nano Titanium Dioxide Market – Opportunities and Forecast 2016 – 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Nano Titanium Dioxide Market

This report studies Nano Titanium Dioxide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Sigma-Aldrich
US Research Nanomaterials, Inc.
Showa America
Gerhold Chemetals Co., Ltd
EPRUI Nanoparticles & Microspheres Co. Ltd
Green Earth Nano Science Inc.
Henan Huier Nano-Technology co.,Ltd
Xuan Cheng Jing Rui New Material Co.,Ltd
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nano Titanium Dioxide in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Request Sample Report @ https://www.wiseguyreports.com/sample-request/743254-global-nano-titanium-dioxide-market-research-report-2016

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Nano Titanium Dioxide in each application, can be divided into
Photocatalyst
Cosmetics
Automotive Topcoat
Other

Complete Report Details @ https://www.wiseguyreports.com/reports/743254-global-nano-titanium-dioxide-market-research-report-2016

Table of Contents

Global Nano Titanium Dioxide Market Research Report 2016
1 Nano Titanium Dioxide Market Overview
1.1 Product Overview and Scope of Nano Titanium Dioxide
1.2 Nano Titanium Dioxide Segment by Type
1.2.1 Global Production Market Share of Nano Titanium Dioxide by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Nano Titanium Dioxide Segment by Application
1.3.1 Nano Titanium Dioxide Consumption Market Share by Application in 2015
1.3.2 Photocatalyst
1.3.3 Cosmetics
1.3.4 Automotive Topcoat
1.3.5 Other
1.4 Nano Titanium Dioxide Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nano Titanium Dioxide (2011-2021)

2 Global Nano Titanium Dioxide Market Competition by Manufacturers
2.1 Global Nano Titanium Dioxide Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nano Titanium Dioxide Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nano Titanium Dioxide Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nano Titanium Dioxide Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nano Titanium Dioxide Market Competitive Situation and Trends
2.5.1 Nano Titanium Dioxide Market Concentration Rate
2.5.2 Nano Titanium Dioxide Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nano Titanium Dioxide Capacity, Production, Revenue (Value) by Region (2011-2016)
3.1 Global Nano Titanium Dioxide Capacity and Market Share by Region (2011-2016)
3.2 Global Nano Titanium Dioxide Production and Market Share by Region (2011-2016)
3.3 Global Nano Titanium Dioxide Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Nano Titanium Dioxide Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Nano Titanium Dioxide Consumption by Regions (2011-2016)
4.2 North America Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Nano Titanium Dioxide Production, Revenue (Value), Price Trend by Type
5.1 Global Nano Titanium Dioxide Production and Market Share by Type (2011-2016)
5.2 Global Nano Titanium Dioxide Revenue and Market Share by Type (2011-2016)
5.3 Global Nano Titanium Dioxide Price by Type (2011-2016)
5.4 Global Nano Titanium Dioxide Production Growth by Type (2011-2016)

..……CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Check Discount on This Report @ https://www.wiseguyreports.com/check-discount/743254-global-nano-titanium-dioxide-market-research-report-2016

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

MediPoint: Body Contouring – Global Analysis and Market Forecasts



Wise.Guy.

MediPoint: Body Contouring – Global Analysis and Market Forecasts

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Body contouring devices are categorized into the following segments: minimally invasive body contouring devices and non-invasive body contouring devices.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729484-medipoint-body-contouring-global-analysis-and-market-forecasts

Minimally invasive body contouring devices include –
– Laser-Assisted Liposuction Devices
– Radiofrequency Assisted Liposuction Devices
– Ultrasound Assisted Liposuction Devices
– Power Assisted Liposuction Devices

Non-invasive body contouring devices include –
– Radiofrequency Energy Devices
– High-Intensity Focused Ultrasound Devices
– Cryolipolysis Devices

Growth in the body contouring devices market is driven primarily by the growing non-invasive devices segment, an increasing global obesity rate, and the aging population.

The global market for body contouring devices is led by Syneron Candela, Cynosure, Solta Medical, and Zeltiq Aesthetics.

Key Questions Answered
– What are the unmet needs with the current generation of devices? Device Effectiveness? Device Efficiency?
– With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global body contouring device market?
– What trends and events are affecting the global market?
– Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products?

Scope
– Competitive assessment: Currently marketed body contouring devices and evolving competitive landscape
– In-depth analysis of unmet needs and adoption trends of different body contouring devices
– Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
– Annualized total body contouring devices market revenue by segment and market outlooks by country from 2013-2022.
– Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global body contouring devices market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global body contouring devices market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track device sales in the global and country-specific body contouring devices market from 2013-2022.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12
2 Introduction 14
2.1 Catalyst 14
2.2 Related Reports 15
3 Market Access 16
3.1 Reimbursement 16
3.2 Regulatory Issues/Recalls 16
3.3 Mergers and Acquisitions 17
3.3.1 The Lumenis Acquisition of Pollogen 18
3.3.2 The Valeant Acquisition of Solta Medical 18
3.3.3 The Cynosure Acquisition of Palomal Medical Technologies 18
3.3.4 The Fosun Acquisition of Alma Lasers 18
3.3.5 The Solta Medical Acquisition of Sound Surgical Technologies 18
4 Unmet Needs 19
4.1 Overview 19
4.2 Understanding of longterm outcomes for newer methods 19
4.3 Understanding the Clinical Outcomes of Combining Multiple Treatment Types 19
4.4 Clinical Measures of Procedure Effectiveness 19
4.5 Procedure Efficiency 20
4.6 Minimizing Post-Procedural Downtime 20
5 Competitive Assessment 21
5.1 Company Share Analysis 21
5.2 Major Players 22
5.2.1 Alma Lasers 22
5.2.2 Cutera 25
5.2.3 CynoSure 27
5.2.4 DEKA 29
5.2.5 Invasix Aesthetic Solutions 31
5.2.6 Lumenis 33
5.2.7 Syneron Candela 37
5.2.8 Solta Medical 39
5.2.9 Venus Concept 42
5.2.10 Zeltiq 44
6 Market Outlooks 47
6.1 Procedure Trends 47
6.2 Market Drivers and Barriers 48
6.2.1 Market Driver: Non-surgical Options 48
6.2.2 Market Driver: Men Getting More Cosmetic Surgery 49
6.2.3 Market Driver: Obesity 49
6.2.4 Market Driver: The Aging Population 49
6.2.5 Market Barrier: No Reimbursement 50
6.2.6 Market Barrier: Alternative Treatment Options 50
6.2.7 Market Barrier: Complications 51
6.2.8 Multiple Treatments Required 52
6.3 Market Outlooks by Segment 52
6.3.1 Minimally Invasive Body Contouring Devices 53
6.3.2 Non-invasive Body Contouring Devices 63
6.4 Market Outlooks by Geography 70
6.4.1 Global 70
6.4.2 Europe 72
6.4.3 Asia-Pacific 82
6.4.4 North America 91
6.4.5 South America 96
7 Appendix 98
7.1 Bibliography 98
7.2 Abbreviations 104
7.3 Methodology 105
7.4 Forecasting Methodology 106
7.4.1 Average Selling Prices 106
7.4.2 Market Segmentation 106
7.4.3 Company Share 106
7.5 Primary Research Efforts 107
7.6 About the Authors 108
7.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 108
7.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 108

Access Report @ https://www.wiseguyreports.com/reports/729484-medipoint-body-contouring-global-analysis-and-market-forecasts

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com